Botox

Botox turns 25

The anniversary celebration for the line-smoothing, migraine-relieving medication is expected to last a year.

Business briefs: Endo; Allergan

Endo gets a new president, Allergan settles a Botox case

Migraine study fails to trigger Allergan headache

Migraine study fails to trigger Allergan headache

By

An April 25 JAMA article said Botox does nothing for episodic migraine patients. Allergan brushed off the critique.

Judge puts freeze on Merz bid to challenge Botox

By

US District Court Judge Andrew Guilford slammed the breaks on Merz's foray into a market dominated by Botox, siding with Allergan in a case about stealing intellectual property and poaching sales reps.

Allergan scrubs some patient data

Allergan scrubs some patient data

By

Allergan removed some doctor-payment records from its website that the drugmaker had posted from 2010-2011 as a result of a Botox legal settlement.

Email Newsletters